Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

86.16
Delayed Data
As of 4:02pm ET
 +1.22 / +1.44%
Today’s Change
66.93
Today|||52-Week Range
86.90
+18.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line9.3B10.6B7.0B6.7B
 
 
 
 
 
Depreciation4.7B4.3B5.2B5.3B
 
 
 
 
 
Total Other Cash Flow-161.9M-559.4M506.1M-508.9M
 
 
 
 
 
Funds From Operations13.9B14.4B12.7B11.5B
 
 
 
 
 
Funds From/For Other Operating Expenses738.5M617.8M861.5M76.8M
 
 
 
 
 
Net Cash Flow - Operating Activities13.1B13.7B11.9B11.5B
 
 
 
 
 
 
InvestingIncrease In Investments-442.7M-403.3M-857.5M-775.3M
 
 
 
 
 
Decrease In Investments563.6M3.8B427.2M867.2M
 
 
 
 
 
Capital Expenditures-3.1B-2.6B-2.4B-1.9B
 
 
 
 
 
Fixed Asset Disposal60.0M59.3M236.6M160.7M
 
 
 
 
 
Net Assets From Acquisitions -42.0M-327.2M-16.5B-763.4M
 
 
 
 
 
Other Investing - Uses-39.0M-59.3M-81.9M-895.1M
 
 
 
 
 
Other Investing - Sources170.9M1.1B9.5B845.2M
 
 
 
 
 
Net Cash Flow Investing-3.3B870.8M-10.8B-3.4B
 
 
 
 
 
 
FinancingShort Term Borrowings595.6M-105.8M450.2M1.8B
 
 
 
 
 
Long Term Borrowings92.9M6.0B4.6B1.9B
 
 
 
 
 
Long Term Debt Reduction-2.0B-2.6B-3.1B-1.7B
 
 
 
 
 
Net Proceeds Stock Sale1.7B0.000.000.00
 
 
Common Preferred Redeemed-2.9B-6.8B-6.1B-1.1B
 
 
 
 
 
Common Dividends-6.1B-6.7B-6.6B-6.5B
 
 
 
 
 
Cash Dividends Paid - Total-6.1B-6.7B-6.6B-6.5B
 
 
 
 
 
Other Sources - Financing4.0M2.4B1.6B220.5M
 
 
 
 
 
Other Uses - Financing102.9M138.4M4.0M6.0M
 
 
 
 
 
Net Cash Flow - Financing-8.8B-8.1B-9.2B-5.3B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash81.9M-291.6M-285.5M-386.2M
 
 
 
 
 
 
Net Change In Cash1.1B6.6B-8.0B2.7B